Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Marketing, Prospective, Multi-Center, Single Arm, Open Label Clinical Study to Evaluate the Safety of a New Inserter Design for Paragard® T380A Intrauterine Copper Contraceptive

NCT05309694 is registered in ClinicalTrials.gov with CooperSurgical Inc. as lead sponsor.

NCT NCT05309694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Marketing, Prospective, Multi-Center, Single Arm, Open Label Clinical Study to Evaluate the Safety of a New Inserter Design for Paragard® T380A Intrauterine Copper Contraceptive
Lead sponsor
CooperSurgical Inc.
Phase
Phase 4
Overall status
Completed
Start date
March 4, 2022
Completion date
December 8, 2022
Enrollment
119 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

contraception